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Abstract Thioredoxin 1 (Trx1) is a key redox control system
within the nucleus, yet little is known about the sensitivity of
nuclear Trx1 to oxidative stress. The present study compared
oxidant-induced changes in the redox states of nuclear Trx1,
cytoplasmic Trx1, and cellular glutathione (GSH). Nuclear
Trx1 was more reducing than cytoplasmic Trx1 and cellular
GSH in proliferating cells. tert-Butylhydroperoxide caused an
increase in the total amount of nuclear Trx1, but this was ac-
companied by a 60 mV oxidation. Thus, the increase in nuclear
Trx1 levels did not correspond to an increase in the overall
reducing capacity of Trx1 in the nucleus.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The function of many proteins is a¡ected by oxidation of
critical cysteine (Cys) residues [1]. Aside from those participat-
ing in structural disul¢des, Cys residues of intracellular pro-
teins are normally maintained in the reduced (thiol) form, but
can be oxidized by peroxides and other oxidants [2]. Thiore-
doxin 1 (Trx1) and glutathione (GSH) are components of
systems that maintain the thiol/disul¢de redox state of re-
dox-sensitive proteins and protect cells from oxidant-mediated
damage. Trx1 reduces protein disul¢des directly and serves as
a reductant for the peroxiredoxins [3]. GSH protects cells
through direct scavenging of peroxides and by serving as a
reductant for GSH peroxidase [4]. The reduced forms of Trx1
and GSH are regenerated by Trx1 reductase and GSH reduc-
tase, respectively, using electrons from reduced nicotinamide
adenine dinucleotide phosphate (NADPH) [4,5].
Oxidative stress causes an increase in the expression of pro-
tective genes under the control of redox-sensitive transcription
factors such as NF-UB and AP1. The DNA-binding activity of
these transcription factors is inhibited by oxidation and en-
hanced by reduction of Cys residues within their DNA-bind-
ing domains [6,7]. In vitro DNA-binding assays suggest that
GSH is a poor reductant for oxidized transcription factors,
and that vicinal dithiol-containing proteins like Trx1 and Ref1
are much more e⁄cient activators of DNA-binding activity
[8]. The reduced form of Trx1 restores DNA-binding activity
to oxidized transcription factors, and redox-inactive mutants
do not serve this function [9].
Reducing conditions in the cytoplasm, including increased
expression of Trx1, inhibit the release of NF-UB from its in-
hibitor protein IUB in the cytoplasm. However, reducing con-
ditions in the nucleus would be expected to enhance the
DNA-binding activity of NF-UB [9]. This suggests that the
redox state of nuclear Trx1 is regulated independently of the
redox state of cytoplasmic Trx1. Distinct pools of GSH exist
within the cell [10]. The redox states of GSH in the cytoplasm,
mitochondria, and endoplasmic reticulum have been deter-
mined through subcellular fractionation and subsequent mea-
surement of GSH and its oxidized form, glutathione disul¢de
(GSSG) [11]. The determination of the redox environment
within the nucleus has been more di⁄cult. Nuclear mem-
branes contain a nuclear pore complex that allows di¡usion
of small compounds like GSH and GSSG during standard
subcellular fractionation protocols [10,12]. Studies using
non-aqueous fractionation [13,14] and GSH-speci¢c £uores-
cent probes in intact cells [15] suggest that the GSH concen-
tration in the nucleus is similar to that in the cytoplasm, but
that a distinct pool of GSH may exist within the nucleus [16].
Unfortunately, these studies focused on GSH and provide no
information on the nuclear redox state.
In this report, we used a Western blot technique which
separates reduced and oxidized Trx1 in nuclear fractions of
THP1 cells to determine nuclear Trx1 redox state in prolifer-
ating cells and following oxidative stress. Results showed that
the redox state of nuclear Trx1 was more reduced than that of
cytoplasmic Trx1 or cellular GSH. Following exposure to a
toxic concentration of tert-butylhydroperoxide (tBH), both
nuclear and cytoplasmic Trx1 were oxidized in parallel with
cellular GSH, but the extent of oxidation of both was consid-
erably less than that of GSH. Thus, the results show that
nuclear Trx1 is normally more reduced than the cytoplasmic
pool but both are relatively protected against oxidation com-
pared to the cellular GSH pool.
2. Materials and methods
2.1. Cell culture conditions
THP1 human monocyte cells were obtained from American Type
Culture Collection (Rockville, MD,USA) and cultured in RPMI-1640
supplemented with 10% fetal bovine serum and penicillin/streptomy-
cin in a humidi¢ed atmosphere of 5% CO2 at 37‡C.
2.2. Subcellular fractionation
Nuclei were isolated based on the procedure of Janssen and Sen
[17], with modi¢cations to allow redox measurements of Trx1 via the
Redox Western blot. Cells were pelleted by centrifugation and lysed in
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hypotonic lysis bu¡er (10 mM HEPES, pH 7.8, 10 mM KCl, 2 mM
MgCl2, 0.1 mM EDTA, 0.2 mM NaF, 0.2 mM Na3VO4W6H2O) with
freshly added protease inhibitors (leupeptin, aprotinin, pepstatin,
phenylmethylsulfonyl £uoride). For Redox Western blots, 50 mM
iodoacetic acid (IAA) was added to the lysis bu¡er and the pH was
adjusted to pH 7.8. The suspensions were incubated on ice for 5 min,
and Nonidet P40 was added to a ¢nal concentration of 0.6%. Follow-
ing centrifugation at 16 000Ug, the pellet (nuclei) and the supernatant
(cytosol) were separated and analyzed by Western blot or Redox
Western blot analysis, as described below.
2.3. Derivatization of protein thiols with IAA
To allow separation of Trx1 according to redox state, extracts were
treated with IAA, which introduces a negative charge for each thiol.
Nuclear and cytosolic proteins were suspended in guanidine^Tris so-
lution (6 M guanidine^HCl, 50 mM Tris, pH 8.3, 3 mM EDTA, 0.5%
Triton X100) supplemented with 50 mM IAA and incubated at 37‡C
for 30 min. Excess IAA was removed by Sephadex chromatography
(MicroSpin G-25 columns, Amersham-Pharmacia, Piscataway, NJ,
USA).
2.4. Redox Western blot analysis
The redox state of Trx1 was determined by a Western blot method
in which the electrophoresis was performed under native conditions to
facilitate separation of the di¡erently charged forms of Trx1 [18,19].
Derivatized proteins (see above) were separated by native polyacryl-
amide gel electrophoresis (PAGE). Gels were electroblotted to poly-
vinylidene di£uoride (PVDF) membranes (Amersham) and probed
with an antibody to Trx1 (American Diagnostica, Greenwich, CT,
USA) and a secondary antibody conjugated to horseradish peroxidase
(HRP; anti-goat IgG^HRP conjugate, Santa Cruz Biotechnology,
Santa Cruz, CA, USA). Bands corresponding to Trx1 were visualized
using chemiluminescent detection (ECL, Amersham) of HRP by ex-
posure of the membranes to X-ray ¢lm (Kodak, Rochester, NY,
USA). Control experiments showed that the antibody provided nearly
equivalent detection of the di¡erent redox forms of Trx1.
2.5. Western blot analysis
Nuclear and cytosolic proteins were separated by discontinuous
sodium dodecyl sulfate (SDS)^PAGE, transferred to PVDF mem-
branes and probed with antibodies speci¢c for Trx1 (American Di-
agnostica), nucleolin (MBL, Nagoya, Japan), and IkB-K (Research
Antibodies, Santa Cruz, CA, USA). HRP-conjugated secondary anti-
bodies were detected by chemiluminescence.
2.6. Measurement of GSH and GSSG by high-performance liquid
chromatography (HPLC)
GSH and GSSG were assayed by HPLC as S-carboxymethyl,
N-dansyl derivatives using Q-glutamylglutamate as an internal stan-
dard [11].
2.7. Calculation of Eh values
The Nernst equation was used to calculate the redox states of GSH
and Trx1. To convert total GSH and GSSG to intracellular concen-
trations, the cell volumes were assumed to be constant, and a con-
version factor of 5 Wl cell volume per mg cell protein was used [20].
For both Trx1 and GSH redox calculations, the intracellular pH was
assumed to be 7.4 and to be unchanged by tBH treatment. In these
calculations, the E0 for the GSH/GSSG couple was 3264 mV at pH
7.4 [21,22], and the E0 for the active site dithiol/disul¢de of Trx1 was
3254 mV at pH 7.4.
3. Results
3.1. Oxidation of the GSH/GSSG pool by tBH
Under normal culture conditions, the GSH pool was pre-
dominantly in the reduced (GSH) form, with only about 2%
in the oxidized (GSSG) form. Upon exposure to the peroxide
tBH, there was a rapid oxidation of GSH to GSSG followed
by a gradual return toward baseline redox conditions (Fig. 1).
Maximal oxidation occurred within 2 min, at which time the
GSH pool was 50% oxidized. The overall pool size remained
constant over the time course of these experiments, indicating
that there was no extensive loss of GSH due to export or
formation of mixed disul¢des with other cellular thiols.
3.2. Determination of the redox states of nuclear and cytosolic
Trx1
In untreated cells, both the nuclear and the cytosolic pools
of Trx1 were predominantly in the fully reduced form; nu-
clear Trx1 was 95% reduced, and cytosolic Trx1 was 85%
reduced (Fig. 2). tBH caused a rapid and transient oxidation
of both pools of Trx1, with maximal oxidation occurring
within 2 min. Redox Western blot analysis of tBH-treated
cells revealed the presence of a band with lower electropho-
retic mobility than those observed in extracts of untreated
cells. This band represents a two-disul¢de form of Trx1 that
contains a non-active site disul¢de in a region proximal to the
active site [23]. This fully oxidized form was undetectable in
control cells, but became 16% and 5% of the total in nuclei
and cytosol, respectively, after 2 min exposure to tBH. Both
the nuclear and the cytosolic pools of Trx1 were oxidized
under these conditions, and both pools became more reduced
over the next 2 h.
3.3. Comparison of the redox potentials for Trx1 and GSH/
GSSG
The Eh value, calculated from the Nernst equation, pro-
vides a quantitative measure of the redox state of a redox-
active couple and allows convenient comparison of di¡erent
reducing systems in cells. In untreated cells, the redox state of
Trx1 was 3280R 10 mV in the cytosol and 3300R 10 mV in
the nucleus (Fig. 3). It should be noted that a 20 mV di¡er-
ence in Eh values corresponds to a 4.6-fold change in the ratio
of oxidized to reduced forms of Trx1. The active site of nu-
clear Trx1 was oxidized by 60 mV within 2 min of tBH ex-
posure, then returned to a level that was 30 mV more oxidized
than baseline within 1 h. Cytosolic Trx1 was oxidized by only
30 mV, but remained more than 20 mV oxidized throughout
the course of the experiment (Fig. 3).
The cellular GSH/GSSG Eh was 3260R 3 mV in untreated
cells, and was oxidized by 70 mV (to 3190R 18 mV) after
2 min tBH exposure (Fig. 3). Even 2 h after tBH treatment,
Fig. 1. GSH is oxidized to GSSG in cells treated with tBH. Cells
were exposed to 1 mM tBH for the indicated times, and cellular
GSH and GSSG was analyzed as described in Section 2. Values are
the meanRS.E.M. of three separate experiments.
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the GSH/GSSG couple was still oxidized by 35 mV. Although
the extent of oxidation of the GSH pool was greater, the
oxidation and subsequent reduction of all three redox pools
(i.e. nuclear Trx1, cytosolic Trx1, and cellular GSH/GSSG)
followed similar time courses.
3.4. Trx1 redistributes to the nucleus following tBH exposure
Trx1 redistributes to the nucleus in response to many stim-
uli, including UV irradiation, phorbol esters, TNF, and hy-
drogen peroxide [9,24]. Because the Redox Western data con-
tained multiple bands, these data did not clearly reveal such
an increase in response to tBH. Therefore, we performed
Western blot analyses to determine whether tBH also caused
an increase in Trx1 in the nucleus. The results showed that the
amount of Trx1 in the nucleus doubled 2 min after tBH, and
was gradually lost over the next 2 h (Fig. 4). Thus, the results
show that oxidation of Trx1 is associated with an accumula-
tion of Trx1 in the nucleus.
4. Discussion
The intracellular environment is normally maintained in a
relatively reduced state [2]. In the present report we show that
the GSH/GSSG couple, the predominant redox bu¡ering sys-
tem, is 3260 mV in THP1 cells under normal culture condi-
tions. This value is very similar to those reported for other cell
lines under proliferating conditions [20,25,26]. In the present
report, tBH treatment resulted in a 70 mV oxidation of the
GSH/GSSG couple (see Fig. 3).
Escherichia coli Trx has been estimated to be about 40%
oxidized [18] to 70% oxidized [27]. In bovine endothelial cells,
Trx1 was completely reduced, and was only slightly oxidized
upon exposure of the cells to 8 mM H2O2 [19]. The structure
of Trx is highly conserved among diverse species, but mam-
malian Trx1 contains three Cys residues in addition to the
two-active-site Cys [28]. We found that Trx1 from human
monocytes was about 90% reduced, and that 1 mM tBH
caused a substantial oxidation of Trx1. The di¡erent response
to peroxides noted between bovine endothelial cells [19] and
Fig. 3. Comparison of the redox states (Eh values) of cellular GSH,
nuclear Trx1, and cytosolic Trx1 in tBH-treated cells. Cells were
treated with 1 mM tBH for the indicated times, and the redox states
of nuclear Trx1, cytosolic Trx1, and cellular GSH were determined
as described in Section 2. Values represent the meanRS.E.M. of
three separate experiments.
Fig. 2. Time course of oxidation of Trx1 from nuclear and cytosolic fractions. Cells were treated with 1 mM tBH for the indicated times, then
nuclear and cytosolic proteins were isolated and analyzed by Redox Western blot as described in Section 2. Shown is a representative blot.
Fig. 4. Nuclear Trx1 is transiently increased following exposure to
tBH. Cells were treated with 1 mM tBH for the indicated times,
then nuclear and cytosolic proteins were isolated and analyzed by
Western blot as described in Section 2.
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human monocytes (Fig. 1) may be due to di¡erences in cell
type or assay conditions, or di¡erences between the responses
to tBH and H2O2. Recently, we reported that the redox state
of the total cellular pool of Trx1 in Caco-2 cells [25] was 90^
95% reduced, corresponding to an Eh value of about 3280
mV. Thus, the redox states of nuclear and cytosolic Trx1 in
proliferating control cells are comparable to those reported
for Trx1 and GSH in other mammalian systems, and are
considerably more reduced than those reported for bacterial
Trx.
A transient increase in the amount of Trx1 occurred in the
nucleus following tBH exposure (Fig. 4). Nuclear transloca-
tion of Trx1 also occurs in response to H2O2, TNF, phorbol
esters, and UV light [9,24]. In principle, either stimulation of
import or inhibition of export from the nucleus can result in
the accumulation of a protein in the nucleus. There are no
recognizable nuclear localization or nuclear export sequences
in Trx1 [5], so it is unclear how the subcellular distribution of
Trx1 is maintained.
Accumulation of Trx1 in the nucleus in response to oxida-
tive stress could provide the necessary reducing equivalents to
allow maximal expression of stress response genes under the
control of redox-sensitive transcription factors like NF-UB
and AP1. In the experiments described here, a decrease in
amount of reduced Trx1 in the nucleus occurred immediately
following tBH exposure (compare lanes 1 and 2 in Fig. 2).
This corresponded to a 60 mV decrease in the overall reducing
capacity of the Trx1 in the nucleus (i.e. a 100-fold increase in
the ratio of the oxidized to reduced forms of Trx1). Thus,
despite the observed increase in the total amount of Trx1 in
the nucleus following tBH (see Fig. 4), there was actually a
decrease in the reducing capacity of the nucleus, suggesting
that redox-sensitive transcription factors were not maximally
active under these conditions. NF-UB mediates the expression
of genes that a¡ord protection against oxidative stress [29],
but a toxic concentration of tBH (1 mM) was used in these
studies; under these conditions, one would not expect to see a
maximal protective e¡ect.
Trx1 and GSH were oxidized to similar extents and over
similar time courses following treatment with 1 mM tBH (Fig.
3). This response to oxidative stress di¡ers from redox
changes induced by changes in cell growth. GSH became
more oxidized in Caco-2 colon carcinoma cells undergoing
spontaneous di¡erentiation, but the redox state of Trx1 did
not change in this model [25]. Thus, although the redox states
of GSH and Trx1 are regulated independently under physio-
logic conditions, both of these thiol/disul¢de pools respond
similarly to an acute oxidative stress. The observed changes
in GSH and Trx1 redox may re£ect their role in the detox-
i¢cation of the peroxide, or may simply re£ect the change in
the overall redox environment within the cell. In either case,
the redox state of Trx1 seems to be, like GSH redox, a useful
marker of oxidative stress. Furthermore, the ability to isolate
the nuclear pool of Trx1 provides a means to speci¢cally
assess oxidative stress in the nuclear compartment.
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